Ad
related to: donor portal grifols
Search results
Results from the Go Local Guru Content Network
Grifols, S.A. ( Catalan: [ˈɡɾifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma –based products, a field in which it is the European leader and largest worldwide, [3] [4] the company also supplies devices, instruments, and reagents for clinical testing laboratories .
Plasmapheresis (from the Greek πλάσμα, plasma, something molded, and ἀφαίρεσις aphairesis, taking away) is the removal, treatment, and return or exchange of blood plasma or components thereof from and to the blood circulation. It is thus an extracorporeal therapy, a medical procedure performed outside the body. [citation needed]
Dr. Grifols pioneered a first-of-its-kind technique called plasmapheresis, where a donor's red blood cells would be returned to the donor's body almost immediately after the separation of the blood plasma. This technique is still in practice today, almost 80 years later. In 1945, Dr. Grifols opened the world's first plasma donation center.
Canadian Plasma Resources (CPR) is a private, for-profit bio-pharmaceutical company and a licensed blood establishment based in Saskatoon, Saskatchewan, Canada.It was founded in 2012 and specializes in the collection of source plasma for further manufacturing and contract-manufacturing of plasma-based bio-pharmaceuticals with operations in Saskatoon (Saskatchewan), Moncton (New Brunswick ...
Grifols shares soared on Thursday after the Spanish drugmaker upgraded its annual profit outlook following a strong quarter. Grifols, which posted a third-quarter net profit of 60 million euros ...
The National Donor Deferral Registry, also known as the (NDDR) is a database of individuals who have tested "reactive" for viral agents like human immunodeficiency viruses (HIV), Hepatitis B virus (HBV), and hepatitis C virus (HCV) and are permanently prohibited from donating plasma. [1]
(Reuters) -Shares in Grifols fell more than 9% on Thursday after credit rating agencies Fitch and S&P downgraded their ratings for the beleaguered Spanish drugmaker, citing lower than expected ...
Grifols shares on Spain's blue-chip index <.IBEX> were down 6.5% to 10.9 euros per share shortly after Glanzmann's announcement, regaining some of the ground lost earlier in the day when it ...
Ad
related to: donor portal grifols